US Patent Issued to King's College London on Nov. 18 for "Vitamin D3 phosphate and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compound and methods for preparing the compound" (British Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,310, issued on Nov. 18, was assigned to King's College London (London).

"Vitamin D3 phosphate and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compound and methods for preparing the compound" was invented by Stuart Allen Jones (London) and Makiko Kawashita (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is the compound vitamin D3 phosphate and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compound and methods for preparing the compound. Also disclosed are methods of treating vitamin D deficiency using the compound. The compound is particularly suitable ...